Document:

EXHIBIT 4.2

                          REGISTRATION RIGHTS AGREEMENT

      This Registration  Rights Agreement (this "Agreement") is made and entered
into as of August 8, 2006, among Able Energy,  Inc., a Delaware corporation (the
"Company"),  and the several purchasers signatory hereto (each such purchaser is
a "Purchaser" and collectively, the "Purchasers").

      This  Agreement is made  pursuant to the  Securities  Purchase  Agreement,
dated as of the  date  hereof  between  the  Company  and  each  Purchaser  (the
"Purchase Agreement").

      The Company and each Purchaser hereby agrees as follows:

   1. Definitions

      Capitalized  terms used and not otherwise  defined herein that are defined
in the  Purchase  Agreement  shall  have the  meanings  given  such terms in the
Purchase  Agreement.  As used in this Agreement,  the following terms shall have
the following meanings:

            "Advice" shall have the meaning set forth in Section 6(d).

            "Effectiveness Date" means, with respect to the initial Registration
      Statement  required to be filed  hereunder,  October  15,  2006 and,  with
      respect to any additional  Registration  Statements  which may be required
      pursuant to Section  3(c),  the 60th  calendar day  following  the date on
      which the Company first knows, or reasonably  should have known, that such
      additional   Registration  Statement  is  required  hereunder;   provided,
      however,  in the event the Company is notified by the Commission  that one
      of the above Registration  Statements will not be reviewed or is no longer
      subject to further review and comments,  the Effectiveness Date as to such
      Registration  Statement  shall be the fifth Trading Day following the date
      on which  the  Company  is so  notified  if such date  precedes  the dates
      required above.

            "Effectiveness  Period"  shall have the meaning set forth in Section
      2(a).

            "Event" shall have the meaning set forth in Section 2(b).

            "Event Date" shall have the meaning set forth in Section 2(b).

            "Filing  Date"  means,  with  respect  to the  initial  Registration
      Statement  required  hereunder,  the 45th  calendar day following the date
      hereof and, with respect to any additional  Registration  Statements which
      may be required  pursuant to Section 3(c), the 15th day following the date
      on which the Company  first knows,  or  reasonably  should have known that
      such additional Registration Statement is required hereunder.

                                       1
<PAGE>

            "Holder" or "Holders"  means the holder or holders,  as the case may
      be, from time to time of Registrable Securities.

            "Indemnified  Party"  shall  have the  meaning  set forth in Section
      5(c).

            "Indemnifying  Party"  shall have the  meaning  set forth in Section
      5(c).

            "Losses" shall have the meaning set forth in Section 5(a).

            "Plan of  Distribution"  shall have the meaning set forth in Section
      2(a).

            "Prospectus"  means  the  prospectus   included  in  a  Registration
      Statement (including,  without limitation,  a prospectus that includes any
      information  previously  omitted  from a  prospectus  filed  as part of an
      effective  registration  statement in reliance upon Rule 430A  promulgated
      under the Securities  Act), as amended or  supplemented  by any prospectus
      supplement,  with  respect to the terms of the  offering of any portion of
      the Registrable  Securities covered by a Registration  Statement,  and all
      other   amendments   and   supplements   to  the   Prospectus,   including
      post-effective  amendments,  and all material incorporated by reference or
      deemed to be incorporated by reference in such Prospectus.

            "Registrable Securities" means (i) all of the shares of Common Stock
      issuable  upon  conversion  in full of the  Debentures,  (ii)  all  shares
      issuable  as  interest  or  principal  on  the  Debentures   assuming  all
      permissible  interest and principal  payments are made in shares of Common
      Stock and the  Debentures  are held  until  maturity,  (iii)  all  Warrant
      Shares,  (iv)  any  additional  shares  issuable  in  connection  with any
      anti-dilution  provisions in the Debentures or the Warrants (in each case,
      without  giving effect to any  limitations  on conversion set forth in the
      Debenture or limitations on exercise set forth in the Warrant) and (v) any
      securities  issued or  issuable  upon any stock  split,  dividend or other
      distribution,  recapitalization  or  similar  event  with  respect  to the
      foregoing.

            "Registration  Statement" means the registration statements required
      to  be  filed  hereunder  and  any  additional   registration   statements
      contemplated  by Section 3(c),  including  (in each case) the  Prospectus,
      amendments and supplements to such  registration  statement or Prospectus,
      including pre- and post-effective  amendments,  all exhibits thereto,  and
      all material  incorporated  by reference or deemed to be  incorporated  by
      reference in such registration statement.

            "Rule 415" means Rule 415 promulgated by the Commission  pursuant to
      the Securities  Act, as such Rule may be amended from time to time, or any
      similar rule or  regulation  hereafter  adopted by the  Commission  having
      substantially the same purpose and effect as such Rule.

            "Rule 424" means Rule 424 promulgated by the Commission  pursuant to
      the Securities  Act, as such Rule may be amended from time to time, or any
      similar rule or  regulation  hereafter  adopted by the  Commission  having
      substantially the same purpose and effect as such Rule.

                                       2
<PAGE>

            "Selling Shareholder Questionnaire" shall have the meaning set forth
      in Section 3(a).

   2. Shelf Registration

            (a) On or prior to each Filing Date,  the Company  shall prepare and
      file with the  Commission a "Shelf"  Registration  Statement  covering the
      resale of 130% of the  Registrable  Securities  on such Filing Date for an
      offering  to be made on a  continuous  basis  pursuant  to Rule  415.  The
      Registration  Statement shall be on Form S-3 (except if the Company is not
      then  eligible to register for resale the  Registrable  Securities on Form
      S-3, in which case such registration shall be on another  appropriate form
      in accordance herewith) and shall contain (unless otherwise directed by at
      least an 85% majority in interest of the Holders)  substantially the "Plan
      of Distribution"  attached hereto as Annex A. Subject to the terms of this
      Agreement,  the Company shall use its best efforts to cause a Registration
      Statement to be declared effective under the Securities Act as promptly as
      possible  after  the  filing  thereof,  but  in  any  event  prior  to the
      applicable Effectiveness Date, and shall use its best efforts to keep such
      Registration  Statement  continuously  effective  under the Securities Act
      until all Registrable  Securities  covered by such Registration  Statement
      have been sold,  or may be sold without  volume  restrictions  pursuant to
      Rule 144(k),  as  determined  by the counsel to the Company  pursuant to a
      written  opinion  letter to such effect,  addressed and  acceptable to the
      Company's  transfer  agent and the affected  Holders  (the  "Effectiveness
      Period").  The Company shall  telephonically  request  effectiveness  of a
      Registration  Statement  as of 5:00 pm Eastern  Time on a Trading Day. The
      Company  shall  immediately  notify  the  Holders  via  facsimile  of  the
      effectiveness of a Registration Statement on the same Trading Day that the
      Company telephonically  confirms effectiveness with the Commission,  which
      shall be the date requested for effectiveness of a Registration Statement.
      The Company  shall,  by 9:30 am Eastern  Time on the Trading Day after the
      Effective  Date  (as  defined  in the  Purchase  Agreement),  file a final
      Prospectus  with the  Commission  as required  by Rule 424.  Failure to so
      notify  the  Holder  within  1  Trading  Day  of  such   notification   of
      effectiveness or failure to file a final Prospectus as a foresaid shall be
      deemed an Event under Section 2(b).

            (b) If: (i) a Registration Statement is not filed on or prior to its
      Filing  Date  (if the  Company  files  a  Registration  Statement  without
      affording the Holders the opportunity to review and comment on the same as
      required  by  Section  3(a),  the  Company  shall  not be  deemed  to have
      satisfied  this clause  (i)),  or (ii) the Company  fails to file with the
      Commission  a  request  for  acceleration  in  accordance  with  Rule  461
      promulgated under the Securities Act, within five Trading Days of the date
      that the Company is notified (orally or in writing,  whichever is earlier)
      by the Commission that a Registration Statement will not be "reviewed," or
      not subject to further review, or (iii) prior to its  Effectiveness  Date,
      the Company fails to file a pre-effective  amendment and otherwise respond
      in  writing  to  comments  made  by the  Commission  in  respect  of  such
      Registration  Statement  within 10  calendar  days  after the  receipt  of
      comments by or notice from the Commission  that such amendment is required
      in order for a Registration Statement to be

                                       3
<PAGE>

      declared effective,  or (iv) a Registration Statement filed or required to
      be filed  hereunder is not declared  effective  by the  Commission  by its
      Effectiveness  Date, or (v) after the  Effectiveness  Date, a Registration
      Statement ceases for any reason to remain continuously effective as to all
      Registrable  Securities  for which it is required to be effective,  or the
      Holders are otherwise not permitted to utilize the  Prospectus  therein to
      resell such Registrable  Securities for more than 20 consecutive  calendar
      days or more than an  aggregate  of 30 calendar  days during any  12-month
      period (which need not be consecutive  calendar  Trading Days and provided
      that,  if such  suspension  of the use of the  Prospectus is in connection
      with the acquisition of All American Plazas, Inc., such period shall be 60
      consecutive  days) (any such  failure or breach  being  referred  to as an
      "Event",  and for  purposes  of clause  (i) or (iv) the date on which such
      Event  occurs,  or for purposes of clause (ii) the date on which such five
      Trading Day period is  exceeded,  or for purposes of clause (iii) the date
      which such 10 calendar day period is  exceeded,  or for purposes of clause
      (v) the date on  which  such 20 or 30  calendar  day  period  (or 60 if in
      connection  with  the  acquisition  of  All  American  Plazas,  Inc.),  as
      applicable,  is  exceeded  being  referred  to as "Event  Date"),  then in
      addition  to any other  rights the  Holders  may have  hereunder  or under
      applicable law, on each such Event Date and on each monthly anniversary of
      each such Event Date (if the applicable Event shall not have been cured by
      such date) until the applicable  Event is cured,  the Company shall pay to
      each Holder an amount in cash, as partial  liquidated damages and not as a
      penalty,  equal to 2% of the aggregate  purchase price paid by such Holder
      pursuant to the Purchase  Agreement for any  Registrable  Securities  then
      held by such  Holder  (except  that,  if the Event is  caused  solely as a
      result of the acquisition of All American Plazas,  Inc., the rate shall be
      1% for the first two months such Event has  occurred  and 2%  thereafter).
      Notwithstanding  anything  herein to the contrary,  the parties agree that
      (1) the Company will not be liable for partial  liquidated  damages  under
      this  Agreement with respect to any Warrants or Warrant Shares and (2) the
      maximum  aggregate  partial  liquidated  damages payable to a Holder under
      this Agreement shall be 24% of the aggregate  Subscription  Amount paid by
      such Holder  pursuant to the Purchase  Agreement.  If the Company fails to
      pay any partial liquidated damages pursuant to this Section in full within
      seven days after the date payable,  the Company will pay interest  thereon
      at a rate  of 18%  per  annum  (or  such  lesser  maximum  amount  that is
      permitted to be paid by applicable law) to the Holder, accruing daily from
      the date such partial liquidated damages are due until such amounts,  plus
      all  such  interest  thereon,  are paid in full.  The  partial  liquidated
      damages pursuant to the terms hereof shall apply on a daily pro-rata basis
      for any portion of a month prior to the cure of an Event.

      3. Registration Procedures.

      In connection with the Company's registration  obligations hereunder,  the
Company shall:

            (a) Not less than  three  Trading  Days  prior to the filing of each
      Registration  Statement  and not less  than one  Trading  Day prior to the
      filing of any related  Prospectus or any  amendment or supplement  thereto
      (including  any  document  that  would be  incorporated  or  deemed  to be
      incorporated therein by reference), the Company shall, (i)

                                       4
<PAGE>

      furnish to each Holder copies of all such documents  proposed to be filed,
      which   documents   (other  than  those   incorporated  or  deemed  to  be
      incorporated  by reference) will be subject to the review of such Holders,
      and (ii)  cause  its  officers  and  directors,  counsel  and  independent
      certified  public  accountants  to respond to such  inquiries  as shall be
      necessary,  in the reasonable opinion of respective counsel to each Holder
      to conduct a reasonable investigation within the meaning of the Securities
      Act.  The  Company  shall not file a  Registration  Statement  or any such
      Prospectus or any amendments or  supplements  thereto to which the Holders
      of a majority of the Registrable  Securities  shall  reasonably  object in
      good faith,  provided  that,  the Company is notified of such objection in
      writing  no later  than 3  Trading  Days  after the  Holders  have been so
      furnished  copies of a  Registration  Statement or 1 Trading Day after the
      Holders  have  been so  furnished  copies  of any  related  Prospectus  or
      amendments or  supplements  thereto.  Each Holder agrees to furnish to the
      Company a completed  Questionnaire  in the form attached to this Agreement
      as Annex B (a  "Selling  Shareholder  Questionnaire")  not  less  than two
      Trading Days prior to the Filing Date or by the end of the fourth  Trading
      Day following the date on which such Holder  receives  draft  materials in
      accordance with this Section.

            (b) (i)  Prepare  and file  with  the  Commission  such  amendments,
      including post-effective  amendments,  to a Registration Statement and the
      Prospectus  used in  connection  therewith  as may be  necessary to keep a
      Registration   Statement  continuously  effective  as  to  the  applicable
      Registrable  Securities for the Effectiveness  Period and prepare and file
      with the Commission  such additional  Registration  Statements in order to
      register  for  resale  under  the  Securities  Act all of the  Registrable
      Securities;   (ii)  cause  the  related   Prospectus   to  be  amended  or
      supplemented by any required  Prospectus  supplement (subject to the terms
      of this Agreement), and as so supplemented or amended to be filed pursuant
      to Rule 424;  (iii)  respond as  promptly  as  reasonably  possible to any
      comments  received  from the  Commission  with  respect to a  Registration
      Statement or any amendment thereto and as promptly as reasonably  possible
      provide the Holders true and complete  copies of all  correspondence  from
      and to the Commission relating to a Registration  Statement (provided that
      the  Company  may excise any  information  contained  therein  which would
      constitute material non-public  information as to any Holder which has not
      executed a confidentiality agreement with the Company); and (iv) comply in
      all material  respects with the  provisions of the  Securities Act and the
      Exchange Act with respect to the disposition of all Registrable Securities
      covered  by a  Registration  Statement  during  the  applicable  period in
      accordance  (subject  to the terms of this  Agreement)  with the  intended
      methods  of  disposition  by  the  Holders   thereof  set  forth  in  such
      Registration  Statement  as  so  amended  or  in  such  Prospectus  as  so
      supplemented.

            (c) If during the  Effectiveness  Period,  the number of Registrable
      Securities at any time exceeds 90% of the number of shares of Common Stock
      then registered in a Registration  Statement,  then the Company shall file
      as soon as reasonably  practicable but in any case prior to the applicable
      Filing Date, an additional  Registration  Statement covering the resale by
      the  Holders  of not less  than  130% of the  number  of such  Registrable
      Securities.

                                       5
<PAGE>

            (d) Notify the Holders of  Registrable  Securities to be sold (which
      notice  shall,   pursuant  to  clauses  (iii)  through  (vi)  hereof,   be
      accompanied by an  instruction to suspend the use of the Prospectus  until
      the requisite  changes have been made) as promptly as reasonably  possible
      (and, in the case of (i)(A) below,  not less than one Trading Day prior to
      such filing) and (if requested by any such Person)  confirm such notice in
      writing no later than one  Trading  Day  following  the day (i)(A)  when a
      Prospectus or any Prospectus  supplement or post-effective  amendment to a
      Registration  Statement is proposed to be filed;  (B) when the  Commission
      notifies the Company whether there will be a "review" of such Registration
      Statement  and  whenever  the  Commission  comments  in  writing  on  such
      Registration  Statement;  and (C) with respect to a Registration Statement
      or any post-effective  amendment, when the same has become effective; (ii)
      of  any  request  by  the   Commission  or  any  other  Federal  or  state
      governmental  authority for  amendments or  supplements  to a Registration
      Statement  or  Prospectus  or for  additional  information;  (iii)  of the
      issuance  by the  Commission  or any other  federal or state  governmental
      authority of any stop order suspending the effectiveness of a Registration
      Statement  covering  any  or  all of  the  Registrable  Securities  or the
      initiation of any Proceedings for that purpose; (iv) of the receipt by the
      Company  of  any  notification  with  respect  to  the  suspension  of the
      qualification  or exemption from  qualification  of any of the Registrable
      Securities for sale in any jurisdiction,  or the initiation or threatening
      of any Proceeding for such purpose;  (v) of the occurrence of any event or
      passage  of  time  that  makes  the  financial  statements  included  in a
      Registration  Statement  ineligible for inclusion therein or any statement
      made  in  a   Registration   Statement  or   Prospectus  or  any  document
      incorporated or deemed to be incorporated  therein by reference  untrue in
      any  material  respect or that  requires any  revisions to a  Registration
      Statement,  Prospectus  or  other  documents  so  that,  in the  case of a
      Registration Statement or the Prospectus,  as the case may be, it will not
      contain  any  untrue  statement  of a  material  fact or omit to state any
      material  fact  required  to be stated  therein or  necessary  to make the
      statements  therein,  in light of the circumstances  under which they were
      made, not misleading;  and (vi) the occurrence or existence of any pending
      corporate  development  with  respect  to the  Company  that  the  Company
      believes may be material and that,  in the  determination  of the Company,
      makes it not in the  best  interest  of the  Company  to  allow  continued
      availability of a Registration Statement or Prospectus;  provided that any
      and all of such information shall remain confidential to each Holder until
      such information  otherwise becomes public,  unless disclosure by a Holder
      is required  by law;  provided,  further,  notwithstanding  each  Holder's
      agreement  to keep such  information  confidential,  the  Holders  make no
      acknowledgement   that  any  such  information  is  material,   non-public
      information.

            (e) Use its best  efforts to avoid the  issuance  of, or, if issued,
      obtain the withdrawal of (i) any order  suspending the  effectiveness of a
      Registration  Statement,  or (ii) any suspension of the  qualification (or
      exemption from  qualification)  of any of the  Registrable  Securities for
      sale in any jurisdiction, at the earliest practicable moment.

            (f) Furnish to each Holder,  without charge,  at least one conformed
      copy of each  such  Registration  Statement  and each  amendment  thereto,
      including financial statements and schedules,  all documents  incorporated
      or deemed to be incorporated  therein by reference to the extent requested
      by such Person,  and all  exhibits to the extent

                                       6
<PAGE>

      requested  by  such  Person  (including  those  previously   furnished  or
      incorporated  by reference)  promptly  after the filing of such  documents
      with the Commission.

            (g)  Subject  to the terms of this  Agreement,  the  Company  hereby
      consents to the use of such  Prospectus  and each  amendment or supplement
      thereto by each of the selling Holders in connection with the offering and
      sale of the  Registrable  Securities  covered by such  Prospectus  and any
      amendment  or  supplement  thereto,  except after the giving of any notice
      pursuant to Section 3(d).

            (h) If NASDR Rule 2710 requires any  broker-dealer  to make a filing
      prior to  executing  a sale by a  Holder,  the  Company  shall (i) make an
      Issuer Filing with the NASDR, Inc. Corporate Financing Department pursuant
      to proposed NASDR Rule 2710(b)(10)(A)(i), (ii) respond within five Trading
      Days to any comments  received from NASDR in connection  therewith,  (iii)
      and pay the filing fee required in connection therewith.

            (i) Prior to any resale of Registrable  Securities by a Holder,  use
      its  commercially  reasonable  efforts to register or qualify or cooperate
      with  the  selling  Holders  in  connection   with  the   registration  or
      qualification  (or exemption from the  Registration or  qualification)  of
      such  Registrable  Securities  for the  resale  by the  Holder  under  the
      securities or Blue Sky laws of such jurisdictions within the United States
      as any Holder reasonably requests in writing, to keep each registration or
      qualification (or exemption  therefrom) effective during the Effectiveness
      Period and to do any and all other acts or things reasonably  necessary to
      enable the disposition in such jurisdictions of the Registrable Securities
      covered by each Registration  Statement;  provided, that the Company shall
      not be required to qualify  generally  to do business in any  jurisdiction
      where it is not then so qualified, subject the Company to any material tax
      in any such jurisdiction where it is not then so subject or file a general
      consent to service of process in any such jurisdiction.

            (j) If  requested  by the  Holders,  cooperate  with the  Holders to
      facilitate   the  timely   preparation   and   delivery  of   certificates
      representing  Registrable  Securities  to  be  delivered  to a  transferee
      pursuant to a Registration Statement, which certificates shall be free, to
      the  extent  permitted  by the  Purchase  Agreement,  of  all  restrictive
      legends,  and  to  enable  such  Registrable  Securities  to  be  in  such
      denominations  and  registered  in such  names  as any  such  Holders  may
      request.

            (k) Upon the occurrence of any event contemplated by this Section 3,
      as promptly as reasonably  possible  under the  circumstances  taking into
      account the Company's good faith assessment of any adverse consequences to
      the Company  and its  stockholders  of the  premature  disclosure  of such
      event,  prepare a  supplement  or  amendment,  including a  post-effective
      amendment,  to a  Registration  Statement or a  supplement  to the related
      Prospectus  or any  document  incorporated  or deemed  to be  incorporated
      therein by  reference,  and file any other  required  document so that, as
      thereafter delivered, neither a Registration Statement nor such Prospectus
      will  contain an untrue  statement  of a material  fact or omit to state a
      material  fact  required  to be stated

                                       7
<PAGE>

      therein  or  necessary  to make the  statements  therein,  in light of the
      circumstances  under which they were made, not misleading.  If the Company
      notifies  the Holders in  accordance  with clauses  (iii)  through (vi) of
      Section  3(d)  above  to  suspend  the  use of any  Prospectus  until  the
      requisite  changes to such  Prospectus  have been made,  then the  Holders
      shall  suspend  use of such  Prospectus.  The  Company  will  use its best
      efforts  to  ensure  that  the use of the  Prospectus  may be  resumed  as
      promptly as is practicable.  The Company shall be entitled to exercise its
      right  under  this  Section  3(k)  to  suspend  the   availability   of  a
      Registration  Statement and Prospectus,  subject to the payment of partial
      liquidated damages pursuant to Section 2(b), for a period not to exceed 90
      calendar days (which need not be consecutive days) in any 12 month period.

            (l)  Comply  with  all  applicable  rules  and  regulations  of  the
      Commission.

            (m) The Company may require  each  selling  Holder to furnish to the
      Company a certified  statement  as to the number of shares of Common Stock
      beneficially owned by such Holder and, if required by the Commission,  the
      natural persons thereof that have voting and dispositive  control over the
      Shares.  During  any  periods  that  the  Company  is  unable  to meet its
      obligations  hereunder with respect to the registration of the Registrable
      Securities  solely  because any Holder fails to furnish  such  information
      within three Trading Days of the Company's request, any liquidated damages
      that are  accruing at such time as to such Holder only shall be tolled and
      any Event that may otherwise  occur solely  because of such delay shall be
      suspended as to such Holder only,  until such  information is delivered to
      the Company.

      4.  Registration   Expenses.   All  fees  and  expenses  incident  to  the
performance  of or compliance  with this Agreement by the Company shall be borne
by the Company whether or not any Registrable  Securities are sold pursuant to a
Registration  Statement.  The fees and  expenses  referred  to in the  foregoing
sentence shall include, without limitation, (i) all registration and filing fees
(including,  without  limitation,  fees and expenses (A) with respect to filings
required  to be made with any Trading  Market on which the Common  Stock is then
listed for trading,  (B) in compliance with applicable  state securities or Blue
Sky laws  reasonably  agreed to by the  Company in writing  (including,  without
limitation, fees and disbursements of counsel for the Company in connection with
Blue  Sky  qualifications  or  exemptions  of  the  Registrable  Securities  and
determination  of the eligibility of the  Registrable  Securities for investment
under the laws of such jurisdictions as requested by the Holders) and (C) if not
previously paid by the Company in connection with an Issuer Filing, with respect
to any filing  that may be  required  to be made by any broker  through  which a
Holder intends to make sales of  Registrable  Securities  with NASD  Regulation,
Inc.  pursuant to the NASD Rule 2710, so long as the broker is receiving no more
than a  customary  brokerage  commission  in  connection  with such  sale,  (ii)
printing  expenses   (including,   without  limitation,   expenses  of  printing
certificates  for  Registrable  Securities and of printing  prospectuses  if the
printing of prospectuses is reasonably requested by the holders of a majority of
the  Registrable  Securities  included  in  a  Registration  Statement),   (iii)
messenger,  telephone  and delivery  expenses,  (iv) fees and  disbursements  of
counsel for the Company, (v) Securities Act liability insurance,  if the Company
so desires  such  insurance,  and (vi) fees and  expenses  of all other  Persons
retained by the Company in connection with the  consummation of the transactions
contemplated  by this Agreement.  In addition,  the Company shall be responsible

                                       8
<PAGE>

for all of its internal expenses incurred in connection with the consummation of
the transactions contemplated by this Agreement (including,  without limitation,
all salaries and expenses of its  officers  and  employees  performing  legal or
accounting  duties),  the expense of any annual  audit and the fees and expenses
incurred in  connection  with the listing of the  Registrable  Securities on any
securities  exchange  as  required  hereunder.  In no event shall the Company be
responsible  for any broker or similar  commissions  of any Holder or, except to
the extent  provided for in the Transaction  Documents,  any legal fees or other
costs of the Holders.

      5. Indemnification

            (a)   Indemnification   by   the   Company.   The   Company   shall,
      notwithstanding  any  termination  of this  Agreement,  indemnify and hold
      harmless each Holder, the officers,  directors, members, partners, agents,
      brokers  (including  brokers who offer and sell Registrable  Securities as
      principal as a result of a pledge or any failure to perform under a margin
      call of Common  Stock),  investment  advisors and employees (and any other
      Persons  with a  functionally  equivalent  role of a Person  holding  such
      titles,  notwithstanding  a lack of such title or any other title) of each
      of them,  each Person who controls any such Holder  (within the meaning of
      Section 15 of the  Securities  Act or Section 20 of the Exchange  Act) and
      the  officers,  directors,  members,  shareholders,  partners,  agents and
      employees (and any other Persons with a functionally  equivalent role of a
      Person  holding such titles,  notwithstanding  a lack of such title or any
      other  title) of each  such  controlling  Person,  to the  fullest  extent
      permitted by applicable law, from and against any and all losses,  claims,
      damages,  liabilities,  costs (including,  without limitation,  reasonable
      attorneys'  fees) and  expenses  (collectively,  "Losses"),  as  incurred,
      arising out of or relating to (1) any untrue or alleged  untrue  statement
      of a material fact contained in a Registration  Statement,  any Prospectus
      or any form of prospectus or in any amendment or supplement  thereto or in
      any preliminary prospectus,  or arising out of or relating to any omission
      or alleged  omission of a material fact  required to be stated  therein or
      necessary to make the statements therein (in the case of any Prospectus or
      form of prospectus or supplement  thereto,  in light of the  circumstances
      under which they were made) not misleading or (2) any violation or alleged
      violation  by the Company of the  Securities  Act, the Exchange Act or any
      state securities law, or any rule or regulation thereunder,  in connection
      with the  performance of its obligations  under this Agreement,  except to
      the extent,  but only to the extent,  that (i) such untrue  statements  or
      omissions  are  based  solely  upon  information   regarding  such  Holder
      furnished  in writing  to the  Company by such  Holder  expressly  for use
      therein,  or to the extent that such information relates to such Holder or
      such Holder's  proposed method of  distribution of Registrable  Securities
      and was  reviewed  and  expressly  approved  in  writing  by  such  Holder
      expressly for use in a  Registration  Statement,  such  Prospectus or such
      form of Prospectus  or in any  amendment or  supplement  thereto (it being
      understood  that the Holder has approved  Annex A hereto for this purpose)
      or (ii) in the case of an occurrence of an event of the type  specified in
      Section 3(d)(iii)-(vi), the use by such Holder of an outdated or defective
      Prospectus  after the Company has notified such Holder in writing that the
      Prospectus  is  outdated  or  defective  and prior to the  receipt by such
      Holder of the Advice  contemplated  in Section  6(d).  The  Company  shall
      notify the Holders promptly of the institution, threat

                                       9
<PAGE>

      or assertion of any  Proceeding  arising  from or in  connection  with the
      transactions contemplated by this Agreement of which the Company is aware.

            (b) Indemnification by Holders. Each Holder shall, severally and not
      jointly, indemnify and hold harmless the Company, its directors, officers,
      agents and  employees,  each Person who controls  the Company  (within the
      meaning of Section 15 of the Securities Act and Section 20 of the Exchange
      Act), and the directors, officers, agents or employees of such controlling
      Persons,  to the fullest  extent  permitted by  applicable  law,  from and
      against all Losses,  as  incurred,  to the extent  arising out of or based
      solely  upon:  (x) such  Holder's  failure to comply  with the  prospectus
      delivery  requirements  of the Securities Act or (y) any untrue or alleged
      untrue  statement  of  a  material  fact  contained  in  any  Registration
      Statement, any Prospectus,  or any form of prospectus, or in any amendment
      or supplement thereto or in any preliminary prospectus,  or arising out of
      or  relating  to any  omission  or alleged  omission  of a  material  fact
      required to be stated therein or necessary to make the statements  therein
      not misleading (i) to the extent, but only to the extent, that such untrue
      statement  or omission is  contained  in any  information  so furnished in
      writing by such Holder to the Company  specifically  for inclusion in such
      Registration  Statement or such Prospectus or (ii) to the extent that such
      information  relates to such Holder's  proposed  method of distribution of
      Registrable  Securities and was reviewed and expressly approved in writing
      by such Holder  expressly  for use in a  Registration  Statement (it being
      understood  that the Holder has approved Annex A hereto for this purpose),
      such  Prospectus  or  such  form  of  Prospectus  or in any  amendment  or
      supplement thereto or (ii) in the case of an occurrence of an event of the
      type  specified  in Section  3(d)(iii)-(vi),  the use by such Holder of an
      outdated or  defective  Prospectus  after the Company  has  notified  such
      Holder in writing that the  Prospectus  is outdated or defective and prior
      to the receipt by such Holder of the Advice  contemplated in Section 6(d).
      In no event shall the liability of any selling Holder hereunder be greater
      in amount  than the dollar  amount of the net  proceeds  received  by such
      Holder  upon the sale of the  Registrable  Securities  giving rise to such
      indemnification obligation.

            (c) Conduct of Indemnification  Proceedings. If any Proceeding shall
      be brought or asserted against any Person entitled to indemnity  hereunder
      (an "Indemnified Party"), such Indemnified Party shall promptly notify the
      Person  from  whom  indemnity  is sought  (the  "Indemnifying  Party")  in
      writing,  and the  Indemnifying  Party  shall have the right to assume the
      defense   thereof,   including  the   employment  of  counsel   reasonably
      satisfactory  to the  Indemnified  Party and the  payment  of all fees and
      expenses incurred in connection with defense thereof;  provided,  that the
      failure of any Indemnified Party to give such notice shall not relieve the
      Indemnifying  Party of its  obligations  or  liabilities  pursuant to this
      Agreement,  except  (and  only) to the  extent  that it  shall be  finally
      determined by a court of competent  jurisdiction  (which  determination is
      not  subject to appeal or further  review)  that such  failure  shall have
      prejudiced the Indemnifying Party.

            An Indemnified Party shall have the right to employ separate counsel
      in any such Proceeding and to participate in the defense thereof,  but the
      fees  and  expenses  of  such  counsel  shall  be at the  expense  of such
      Indemnified Party or Parties unless: (1) the Indemnifying Party has agreed
      in writing to pay such fees and expenses; (2) the

                                       10
<PAGE>

      Indemnifying  Party  shall have  failed  promptly to assume the defense of
      such  Proceeding and to employ  counsel  reasonably  satisfactory  to such
      Indemnified Party in any such Proceeding;  or (3) the named parties to any
      such  Proceeding  (including  any  impleaded  parties)  include  both such
      Indemnified  Party  and  the  Indemnifying   Party,  and  counsel  to  the
      Indemnified  Party shall  reasonably  believe that a material  conflict of
      interest is likely to exist if the same  counsel  were to  represent  such
      Indemnified  Party and the  Indemnifying  Party (in  which  case,  if such
      Indemnified  Party  notifies  the  Indemnifying  Party in writing  that it
      elects to employ  separate  counsel  at the  expense  of the  Indemnifying
      Party,  the  Indemnifying  Party  shall not have the  right to assume  the
      defense  thereof and the reasonable  fees and expenses of no more than one
      separate counsel shall be at the expense of the Indemnifying  Party).  The
      Indemnifying  Party  shall not be liable  for any  settlement  of any such
      Proceeding  effected without its written consent,  which consent shall not
      be unreasonably  withheld or delayed. No Indemnifying Party shall, without
      the prior written consent of the Indemnified Party,  effect any settlement
      of any pending  Proceeding in respect of which any Indemnified  Party is a
      party,  unless such settlement  includes an unconditional  release of such
      Indemnified Party from all liability on claims that are the subject matter
      of such Proceeding.

            Subject  to the terms of this  Agreement,  all  reasonable  fees and
      expenses of the Indemnified Party (including  reasonable fees and expenses
      to the extent  incurred in connection with  investigating  or preparing to
      defend such  Proceeding  in a manner not  inconsistent  with this Section)
      shall be paid to the Indemnified  Party,  as incurred,  within ten Trading
      Days of written notice thereof to the Indemnifying Party;  provided,  that
      the Indemnified Party shall promptly  reimburse the Indemnifying Party for
      that  portion of such fees and  expenses  applicable  to such  actions for
      which such Indemnified  Party is judicially  determined to be not entitled
      to indemnification hereunder.

            (d) Contribution.  If the indemnification under Section 5(a) or 5(b)
      is  unavailable  to an  Indemnified  Party  or  insufficient  to  hold  an
      Indemnified Party harmless for any Losses,  then each  Indemnifying  Party
      shall contribute to the amount paid or payable by such Indemnified  Party,
      in such  proportion as is appropriate to reflect the relative fault of the
      Indemnifying  Party and Indemnified  Party in connection with the actions,
      statements or omissions  that resulted in such Losses as well as any other
      relevant equitable considerations. The relative fault of such Indemnifying
      Party and  Indemnified  Party shall be  determined  by reference to, among
      other  things,  whether any action in  question,  including  any untrue or
      alleged  untrue  statement  of a  material  fact or  omission  or  alleged
      omission  of a  material  fact,  has been  taken or made by, or relates to
      information supplied by, such Indemnifying Party or Indemnified Party, and
      the  parties'  relative  intent,  knowledge,  access  to  information  and
      opportunity to correct or prevent such action,  statement or omission. The
      amount  paid or  payable  by a party as a result  of any  Losses  shall be
      deemed to include, subject to the limitations set forth in this Agreement,
      any reasonable attorneys' or other reasonable fees or expenses incurred by
      such party in  connection  with any  Proceeding  to the extent  such party
      would  have  been   indemnified   for  such  fees  or   expenses   if  the
      indemnification  provided for in this Section was  available to such party
      in accordance with its terms.

                                       11
<PAGE>

            The parties  hereto agree that it would not be just and equitable if
      contribution  pursuant to this  Section 5(d) were  determined  by pro rata
      allocation  or by any other method of  allocation  that does not take into
      account  the  equitable  considerations  referred  to in  the  immediately
      preceding paragraph.  Notwithstanding the provisions of this Section 5(d),
      no Holder shall be required to contribute, in the aggregate, any amount in
      excess of the amount by which the net proceeds  actually  received by such
      Holder  from  the  sale  of  the  Registrable  Securities  subject  to the
      Proceeding  exceeds  the  amount  of any  damages  that  such  Holder  has
      otherwise  been required to pay by reason of such untrue or alleged untrue
      statement or omission or alleged omission.

            The indemnity and contribution  agreements contained in this Section
      are in addition to any liability that the Indemnifying Parties may have to
      the Indemnified Parties.

   6. Miscellaneous

      (a) Remedies.  In the event of a breach by the Company or by a Holder,  of
any of their  respective  obligations  under this Agreement,  each Holder or the
Company,  as the case may be, in  addition to being  entitled  to  exercise  all
rights granted by law and under this Agreement,  including  recovery of damages,
will be entitled to specific performance of its rights under this Agreement. The
Company and each Holder agree that monetary  damages would not provide  adequate
compensation  for any losses  incurred by reason of a breach by it of any of the
provisions of this Agreement and hereby further agrees that, in the event of any
action for specific  performance in respect of such breach,  it shall not assert
or shall waive the defense that a remedy at law would be adequate.

      (b) No Piggyback on  Registrations.  Except as set forth on Schedule  6(b)
attached hereto, neither the Company nor any of its security holders (other than
the Holders in such  capacity  pursuant  hereto) may include  securities  of the
Company  in the  initial  Registration  Statement  other  than  the  Registrable
Securities.  The Company shall not file any other registration  statements until
the initial  Registration  Statement required hereunder is declared effective by
the  Commission,  provided that this Section 6(b) shall not prohibit the Company
from filing amendments to registration statements already filed.

      (c) Compliance.  Each Holder covenants and agrees that it will comply with
the prospectus  delivery  requirements of the Securities Act as applicable to it
in connection  with sales of Registrable  Securities  pursuant to a Registration
Statement.

      (d)  Discontinued  Disposition.  Each Holder agrees by its  acquisition of
Registrable  Securities  that,  upon receipt of a notice from the Company of the
occurrence of any event of the kind described in Section 3(d)(iii) through (vi),
such  Holder  will  forthwith   discontinue   disposition  of  such  Registrable
Securities  under a Registration  Statement  until it is advised in writing (the
"Advice") by the Company that the use of the  applicable  Prospectus  (as it may
have been supplemented or amended) may be resumed. The Company will use its best
efforts to ensure that the use of the  Prospectus  may be resumed as promptly as
it  practicable.  The Company  agrees and  acknowledges  that any periods during
which the Holder is required to

                                       12
<PAGE>

discontinue  the disposition of the  Registrable  Securities  hereunder shall be
subject to the provisions of Section 2(b).

      (e)  Piggy-Back  Registrations.  If at any time  during the  Effectiveness
Period  there is not an  effective  Registration  Statement  covering all of the
Registrable  Securities and the Company shall determine to prepare and file with
the  Commission  a  registration  statement  relating to an offering for its own
account or the account of others under the  Securities  Act of any of its equity
securities,  other than on Form S-4 or Form S-8 (each as  promulgated  under the
Securities Act) or their then  equivalents  relating to equity  securities to be
issued solely in connection  with any  acquisition  of any entity or business or
equity securities issuable in connection with the stock option or other employee
benefit  plans,  then the Company shall send to each Holder a written  notice of
such  determination  and, if within  fifteen days after the date of such notice,
any such Holder shall so request in writing,  the Company  shall include in such
registration  statement  all or any  part of such  Registrable  Securities  such
Holder requests to be registered; provided, however, that, the Company shall not
be required to register any Registrable Securities pursuant to this Section 6(e)
that are  eligible  for resale  pursuant  to Rule 144(k)  promulgated  under the
Securities  Act  or  that  are  the  subject  of a then  effective  Registration
Statement;  provided, further, that the Company shall not be required to include
such  Registrable  Securities  in an  underwritten  offering  solely of  Company
securities if the managing  underwriter(s) advises the Company that inclusion of
such Registrable Securities would adversely affect such offering.

      (f) Amendments and Waivers.  The provisions of this  Agreement,  including
the provisions of this sentence,  may not be amended,  modified or supplemented,
and waivers or  consents to  departures  from the  provisions  hereof may not be
given,  unless the same shall be in writing  and signed by the  Company  and the
Holders  of  66%  or  more  of  the  then  outstanding  Registrable  Securities.
Notwithstanding the foregoing, a waiver or consent to depart from the provisions
hereof  with  respect  to a matter  that  relates  exclusively  to the rights of
Holders  and that does not  directly  or  indirectly  affect the rights of other
Holders may be given by Holders of all of the  Registrable  Securities  to which
such waiver or consent relates;  provided,  however, that the provisions of this
sentence may not be amended, modified, or supplemented except in accordance with
the provisions of the immediately preceding sentence.

      (g) Notices.  Any and all notices or other  communications  or  deliveries
required or permitted to be provided  hereunder  shall be delivered as set forth
in the Purchase Agreement.

      (h) Successors and Assigns.  This Agreement  shall inure to the benefit of
and be binding upon the successors and permitted  assigns of each of the parties
and shall  inure to the  benefit  of each  Holder.  The  Company  may not assign
(except by merger) its rights or obligations hereunder without the prior written
consent of all of the Holders of the  then-outstanding  Registrable  Securities.
Each Holder may assign their  respective  rights  hereunder in the manner and to
the Persons as permitted under the Purchase Agreement.

      (i)  No  Inconsistent  Agreements.  Neither  the  Company  nor  any of its
Subsidiaries has entered, as of the date hereof, nor shall the Company or any of
its  Subsidiaries,  on or  after  the  date of this  Agreement,  enter  into any
agreement  with  respect  to its  securities,  that  would  have

                                       13
<PAGE>

the effect of impairing the rights  granted to the Holders in this  Agreement or
otherwise conflicts with the provisions hereof.  Except as set forth on Schedule
6(i),  neither the Company nor any of its  subsidiaries  has previously  entered
into any agreement  granting any registration  rights with respect to any of its
securities to any Person that have not been satisfied in full.

      (j) Execution and  Counterparts.  This Agreement may be executed in two or
more counterparts,  all of which when taken together shall be considered one and
the same agreement and shall become effective when counterparts have been signed
by each party and delivered to the other party,  it being  understood  that both
parties need not sign the same  counterpart.  In the event that any signature is
delivered by facsimile  transmission  or by e-mail  delivery of a ".pdf"  format
data file,  such  signature  shall create a valid and binding  obligation of the
party  executing (or on whose behalf such  signature is executed)  with the same
force and effect as if such facsimile or ".pdf"  signature page were an original
thereof.

      (k) Governing Law. All questions  concerning the  construction,  validity,
enforcement  and  interpretation  of  this  Agreement  shall  be  determined  in
accordance with the provisions of the Purchase Agreement.

      (l) Cumulative  Remedies.  The remedies provided herein are cumulative and
not exclusive of any other remedies provided by law.

      (m) Severability.  If any term, provision, covenant or restriction of this
Agreement is held by a court of competent  jurisdiction to be invalid,  illegal,
void or  unenforceable,  the remainder of the terms,  provisions,  covenants and
restrictions set forth herein shall remain in full force and effect and shall in
no way be affected,  impaired or  invalidated,  and the parties hereto shall use
their commercially reasonable efforts to find and employ an alternative means to
achieve the same or substantially  the same result as that  contemplated by such
term, provision,  covenant or restriction.  It is hereby stipulated and declared
to be the  intention of the parties that they would have  executed the remaining
terms, provisions, covenants and restrictions without including any of such that
may be hereafter declared invalid, illegal, void or unenforceable.

      (n) Headings.  The headings in this Agreement are for convenience only, do
not  constitute  a part of the  Agreement  and  shall  not be deemed to limit or
affect any of the provisions hereof.

      (o) Independent Nature of Holders' Obligations and Rights. The obligations
of each Holder  hereunder are several and not joint with the  obligations of any
other Holder  hereunder,  and no Holder shall be  responsible in any way for the
performance of the obligations of any other Holder hereunder.  Nothing contained
herein or in any other  agreement or document  delivered at any closing,  and no
action  taken by any  Holder  pursuant  hereto  or  thereto,  shall be deemed to
constitute the Holders as a partnership,  an association, a joint venture or any
other kind of entity,  or create a  presumption  that the Holders are in any way
acting  in  concert  with  respect  to  such  obligations  or  the  transactions
contemplated  by this  Agreement.  Each Holder  shall be entitled to protect and
enforce its rights,  including without limitation the rights arising out of this
Agreement, and it shall not be necessary for any other Holder to be joined as an
additional party in any proceeding for such purpose.

                              ********************

                                       14
<PAGE>

      IN WITNESS  WHEREOF,  the parties have executed this  Registration  Rights
Agreement as of the date first written above.

                                ABLE ENERGY, INC.

                                By:__________________________________________
                                   Name:
                                   Title:

                       [SIGNATURE PAGE OF HOLDERS FOLLOWS]

                                       15
<PAGE>

                     [SIGNATURE PAGE OF HOLDERS TO ABLE RRA]

Name of Holder: __________________________
Signature of Authorized Signatory of Holder: __________________________
Name of Authorized Signatory: _________________________
Title of Authorized Signatory: __________________________

                           [SIGNATURE PAGES CONTINUE]

                                       16
<PAGE>

                              Plan of Distribution

      Each Selling Stockholder (the "Selling  Stockholders") of the common stock
and any of their pledgees,  assignees and successors-in-interest  may, from time
to time,  sell any or all of their shares of common stock on the Nasdaq  Capital
Market or any other  stock  exchange,  market or trading  facility  on which the
shares  are traded or in private  transactions.  These  sales may be at fixed or
negotiated  prices.  A  Selling  Stockholder  may  use  any  one or  more of the
following methods when selling shares:

            o     ordinary brokerage  transactions and transactions in which the
                  broker-dealer solicits purchasers;

            o     block trades in which the  broker-dealer  will attempt to sell
                  the shares as agent but may  position  and resell a portion of
                  the block as principal to facilitate the transaction;

            o     purchases by a  broker-dealer  as principal  and resale by the
                  broker-dealer for its account;

            o     an exchange  distribution  in accordance with the rules of the
                  applicable exchange;

            o     privately negotiated transactions;

            o     settlement  of short sales  entered  into after the  effective
                  date of the registration statement of which this prospectus is
                  a part;

            o     broker-dealers may agree with the Selling Stockholders to sell
                  a specified  number of such shares at a  stipulated  price per
                  share;

            o     through the writing or  settlement of options or other hedging
                  transactions,   whether   through  an  options   exchange   or
                  otherwise;

            o     a combination of any such methods of sale; or

            o     any other method permitted pursuant to applicable law.

      The Selling  Stockholders  may also sell  shares  under Rule 144 under the
Securities Act of 1933, as amended (the "Securities Act"), if available,  rather
than under this prospectus.

      Broker-dealers  engaged by the Selling  Stockholders may arrange for other
brokers-dealers to participate in sales.  Broker-dealers may receive commissions
or discounts from the Selling  Stockholders  (or, if any  broker-dealer  acts as
agent  for the  purchaser  of  shares,  from the  purchaser)  in  amounts  to be
negotiated,  but, except as set forth in a supplement to this Prospectus, in the
case of an agency transaction not in excess of a customary brokerage  commission
in compliance with NASDR Rule 2440; and in the case of a principal transaction a
markup or markdown in compliance with NASDR IM-2440.

                                       17
<PAGE>

      In connection with the sale of the common stock or interests therein,  the
Selling  Stockholders may enter into hedging transactions with broker-dealers or
other  financial  institutions,  which may in turn  engage in short sales of the
common stock in the course of hedging the  positions  they  assume.  The Selling
Stockholders  may also sell shares of the common  stock short and deliver  these
securities  to close out their  short  positions,  or loan or pledge  the common
stock to  broker-dealers  that in turn may sell these  securities.  The  Selling
Stockholders   may  also  enter   into   option  or  other   transactions   with
broker-dealers  or other  financial  institutions or the creation of one or more
derivative  securities which require the delivery to such broker-dealer or other
financial  institution of shares offered by this  prospectus,  which shares such
broker-dealer  or  other  financial  institution  may  resell  pursuant  to this
prospectus (as supplemented or amended to reflect such transaction).

      The  Selling  Stockholders  and any  broker-dealers  or  agents  that  are
involved  in selling  the shares may be deemed to be  "underwriters"  within the
meaning of the Securities Act in connection with such sales. In such event,  any
commissions  received  by such  broker-dealers  or agents  and any profit on the
resale  of the  shares  purchased  by  them  may be  deemed  to be  underwriting
commissions or discounts under the Securities Act. Each Selling  Stockholder has
informed  the  Company  that it does not have any written or oral  agreement  or
understanding,  directly or indirectly, with any person to distribute the Common
Stock. In no event shall any broker-dealer receive fees, commissions and markups
which, in the aggregate, would exceed eight percent (8%).

      The Company is required to pay certain fees and  expenses  incurred by the
Company  incident to the  registration of the shares.  The Company has agreed to
indemnify the Selling Stockholders against certain losses,  claims,  damages and
liabilities, including liabilities under the Securities Act.

      Because Selling Stockholders may be deemed to be "underwriters" within the
meaning of the Securities  Act, they will be subject to the prospectus  delivery
requirements of the Securities Act including Rule 172  thereunder.  In addition,
any  securities  covered by this  prospectus  which qualify for sale pursuant to
Rule 144 under the  Securities  Act may be sold under Rule 144 rather than under
this  prospectus.  There is no  underwriter  or  coordinating  broker  acting in
connection  with  the  proposed  sale  of  the  resale  shares  by  the  Selling
Stockholders.

      We agreed to keep this  prospectus  effective until the earlier of (i) the
date on which  the  shares  may be resold by the  Selling  Stockholders  without
registration  and  without  regard to any volume  limitations  by reason of Rule
144(k) under the  Securities Act or any other rule of similar effect or (ii) all
of the shares have been sold  pursuant to this  prospectus or Rule 144 under the
Securities  Act or any other rule of similar  effect.  The resale shares will be
sold only through  registered or licensed  brokers or dealers if required  under
applicable  state securities  laws. In addition,  in certain states,  the resale
shares may not be sold unless they have been registered or qualified for sale in
the applicable  state or an exemption  from the  registration  or  qualification
requirement is available and is complied with.

      Under applicable rules and regulations  under the Exchange Act, any person
engaged in the distribution of the resale shares may not  simultaneously  engage
in market making  activities with respect to the common stock for the applicable
restricted  period, as defined in Regulation

                                       18
<PAGE>

M, prior to the  commencement  of the  distribution.  In  addition,  the Selling
Stockholders  will be subject to  applicable  provisions of the Exchange Act and
the rules and regulations  thereunder,  including  Regulation M, which may limit
the timing of  purchases  and sales of shares of the common stock by the Selling
Stockholders  or any  other  person.  We will  make  copies  of this  prospectus
available  to the Selling  Stockholders  and have  informed  them of the need to
deliver a copy of this  prospectus to each  purchaser at or prior to the time of
the sale (including by compliance with Rule 172 under the Securities Act).

                                       19
<PAGE>

                                ABLE ENERGY, INC.

                 Selling Securityholder Notice and Questionnaire

      The  undersigned  beneficial  owner of common stock,  par value $0.001 per
share (the "Common Stock"),  of Able Energy,  Inc., a Delaware  corporation (the
"Company"),  (the  "Registrable  Securities")  understands  that the Company has
filed or  intends  to file with the  Securities  and  Exchange  Commission  (the
"Commission")   a  registration   statement  on  Form  S-3  (the   "Registration
Statement") for the registration and resale under Rule 415 of the Securities Act
of 1933, as amended (the "Securities  Act"), of the Registrable  Securities,  in
accordance  with the terms of the  Registration  Rights  Agreement,  dated as of
August ____, 2006 (the "Registration  Rights Agreement"),  among the Company and
the Purchasers  named therein.  A copy of the  Registration  Rights Agreement is
available  from the Company  upon  request at the address set forth  below.  All
capitalized  terms not otherwise defined herein shall have the meanings ascribed
thereto in the Registration Rights Agreement.

      Certain   legal   consequences   arise  from  being  named  as  a  selling
securityholder  in  the  Registration  Statement  and  the  related  prospectus.
Accordingly, holders and beneficial owners of Registrable Securities are advised
to consult their own securities law counsel  regarding the consequences of being
named  or not  being  named  as a  selling  securityholder  in the  Registration
Statement and the related prospectus.

                                     NOTICE

      The  undersigned  beneficial  owner  (the  "Selling   Securityholder")  of
Registrable Securities hereby elects to include the Registrable Securities owned
by it and listed below in Item 3 (unless otherwise  specified under such Item 3)
in the Registration Statement.

                                       20
<PAGE>

The  undersigned  hereby  provides the following  information to the Company and
represents and warrants that such information is accurate:

                                  QUESTIONNAIRE

1.    Name.

      (a)   Full Legal Name of Selling Securityholder

            --------------------------------------------------------------------

      (b)   Full Legal Name of Registered  Holder (if not the same as (a) above)
            through  which  Registrable  Securities  Listed  in Item 3 below are
            held:

            --------------------------------------------------------------------

      (c)   Full Legal Name of Natural  Control  Person  (which  means a natural
            person who directly or indirectly  alone or with others has power to
            vote or dispose of the securities covered by the questionnaire):

            --------------------------------------------------------------------

2.    Address for Notices to Selling Securityholder:

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------
Telephone:
          ----------------------------------------------------------------------
Fax:
    ----------------------------------------------------------------------------
Contact Person:
               -----------------------------------------------------------------

3.    Beneficial Ownership of Registrable Securities:

      (a)   Type and Principal  Amount of  Registrable  Securities  beneficially
            owned (not including the  Registrable  Securities  that are issuable
            pursuant to the Purchase Agreement):

            --------------------------------------------------------------------

            --------------------------------------------------------------------

            --------------------------------------------------------------------

                                       21
<PAGE>

4.    Broker-Dealer Status:

      (a)   Are you a broker-dealer?

                               Yes |_|     No |_|

      (b)   If  "yes"  to  Section  4(a),  did  you  receive  your   Registrable
            Securities as compensation  for investment  banking  services to the
            Company.

                               Yes |_|     No |_|

      Note:  If no,  the  Commission's  staff has  indicated  that you should be
             identified as an underwriter in the Registration Statement.

      (c)   Are you an affiliate of a broker-dealer?

                               Yes |_|     No |_|

      (d)   If you are an affiliate of a broker-dealer,  do you certify that you
            bought  the  Registrable   Securities  in  the  ordinary  course  of
            business,  and  at  the  time  of the  purchase  of the  Registrable
            Securities to be resold,  you had no  agreements or  understandings,
            directly  or   indirectly,   with  any  person  to  distribute   the
            Registrable Securities?

                               Yes |_|     No |_|

      Note:  If no,  the  Commission's  staff has  indicated  that you should be
             identified as an underwriter in the Registration Statement.

5.    Beneficial  Ownership  of Other  Securities  of the  Company  Owned by the
      Selling Securityholder.

      Except  as set  forth  below in this  Item 5, the  undersigned  is not the
      beneficial or registered owner of any securities of the Company other than
      the Registrable Securities listed above in Item 3.

      (a)   Type  and  Amount  of  Other  Securities  beneficially  owned by the
            Selling Securityholder:

            --------------------------------------------------------------------

            --------------------------------------------------------------------

            --------------------------------------------------------------------

                                       22
<PAGE>

6.    Relationships with the Company:

      Except as set forth below, neither the undersigned nor any of its
      affiliates, officers, directors or principal equity holders (owners of
      5% of more of the equity securities of the undersigned) has held any
      position or office or has had any other material relationship with the
      Company (or its predecessors or affiliates) during the past three
      years.

      State any exceptions here:

      -----------------------------------------------------------------------

      -----------------------------------------------------------------------

      The undersigned  agrees to promptly notify the Company of any inaccuracies
or changes in the information  provided herein that may occur  subsequent to the
date hereof at any time while the Registration Statement remains effective.

      By signing  below,  the  undersigned  consents  to the  disclosure  of the
information  contained  herein  in its  answers  to  Items 1  through  6 and the
inclusion of such  information  in the  Registration  Statement  and the related
prospectus  and  any  amendments  or  supplements   thereto.   The   undersigned
understands  that  such  information  will  be  relied  upon by the  Company  in
connection with the preparation or amendment of the  Registration  Statement and
the related prospectus.

      IN WITNESS WHEREOF the  undersigned,  by authority duly given,  has caused
this Notice and  Questionnaire  to be executed and delivered either in person or
by its duly authorized agent.

Dated:                                Beneficial Owner:
       ------------------------------                   ------------------------

                                      By:
                                           -------------------------------------
                                           Name:
                                           Title:

PLEASE FAX A COPY OF THE COMPLETED AND EXECUTED  NOTICE AND  QUESTIONNAIRE,  AND
RETURN THE ORIGINAL BY OVERNIGHT MAIL, TO:

                                       23EXHIBIT 4.3

NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE
HAVE  BEEN  REGISTERED  WITH  THE  SECURITIES  AND  EXCHANGE  COMMISSION  OR THE
SECURITIES   COMMISSION  OF  ANY  STATE  IN  RELIANCE  UPON  AN  EXEMPTION  FROM
REGISTRATION  UNDER THE  SECURITIES  ACT OF 1933,  AS AMENDED  (THE  "SECURITIES
ACT"),  AND,  ACCORDINGLY,  MAY NOT BE OFFERED  OR SOLD  EXCEPT  PURSUANT  TO AN
EFFECTIVE  REGISTRATION  STATEMENT  UNDER THE  SECURITIES  ACT OR PURSUANT TO AN
AVAILABLE  EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE  REGISTRATION
REQUIREMENTS  OF THE  SECURITIES  ACT AND IN ACCORDANCE  WITH  APPLICABLE  STATE
SECURITIES  LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO
SUCH  EFFECT,  THE  SUBSTANCE  OF WHICH SHALL BE  REASONABLY  ACCEPTABLE  TO THE
COMPANY.  THIS  SECURITY  AND THE  SECURITIES  ISSUABLE  UPON  EXERCISE  OF THIS
SECURITY MAY BE PLEDGED IN CONNECTION  WITH A BONA FIDE MARGIN  ACCOUNT OR OTHER
LOAN SECURED BY SUCH SECURITIES.

                          COMMON STOCK PURCHASE WARRANT

                To Purchase __________ Shares of Common Stock of

                                ABLE ENERGY, INC.

            THIS COMMON STOCK PURCHASE  WARRANT (the "Warrant")  certifies that,
for value received,  _____________ (the "Holder"),  is entitled,  upon the terms
and subject to the  limitations on exercise and the conditions  hereinafter  set
forth, at any time on or after the date hereof (the "Initial Exercise Date") and
on or prior to the close of business on the five year anniversary of the Initial
Exercise Date (the "Termination Date") but not thereafter,  to subscribe for and
purchase from Able Energy, Inc., a Delaware  corporation (the "Company"),  up to
______  shares (the  "Warrant  Shares") of Common  Stock,  par value  $0.001 per
share, of the Company (the "Common Stock").

      Section 1.  Definitions.  Capitalized terms used and not otherwise defined
herein shall have the meanings  set forth in that  certain  Securities  Purchase
Agreement (the "Purchase  Agreement"),  dated August 8, 2006,  among the Company
and the purchasers signatory thereto.

      Section 2. Exercise.

            a) Exercise of Warrant.  Exercise of the purchase rights represented
      by this Warrant may be made,  in whole or in part, at any time or times on
      or after the Initial  Exercise Date and on or before the Termination  Date
      by delivery to the Company of a duly executed facsimile copy of the Notice
      of Exercise  Form  annexed  hereto (or such other  office or agency of the
      Company as it may designate by notice in writing to the registered  Holder
      at the address of such Holder appearing on the books of the Company); and,
      within 3 Trading  Days of the date said Notice of Exercise is delivered to
      the

                                       1
<PAGE>

      Company, the Company shall have received payment of the aggregate Exercise
      Price of the shares thereby  purchased by wire transfer or cashier's check
      drawn on a United  States  bank.  Notwithstanding  anything  herein to the
      contrary,  the Holder shall not be required to physically  surrender  this
      Warrant to the Company  until the Holder has  purchased all of the Warrant
      Shares available  hereunder and the Warrant has been exercised in full, in
      which case,  the Holder  shall  surrender  this Warrant to the Company for
      cancellation  within  3  Trading  Days of the  date the  final  Notice  of
      Exercise is delivered to the  Company.  Partial  exercises of this Warrant
      resulting in purchases of a portion of the total number of Warrant  Shares
      available  hereunder  shall have the effect of  lowering  the  outstanding
      number of Warrant Shares  purchasable  hereunder in an amount equal to the
      applicable number of Warrant Shares purchased.  The Holder and the Company
      shall maintain  records showing the number of Warrant Shares purchased and
      the date of such purchases. The Company shall deliver any objection to any
      Notice of Exercise  Form within 1 Business  Day of receipt of such notice.
      In the event of any  dispute  or  discrepancy,  the  records of the Holder
      shall be controlling and  determinative  in the absence of manifest error.
      The Holder and any assignee,  by  acceptance of this Warrant,  acknowledge
      and agree that, by reason of the provisions of this  paragraph,  following
      the purchase of a portion of the Warrant Shares  hereunder,  the number of
      Warrant Shares  available for purchase  hereunder at any given time may be
      less than the amount stated on the face hereof.

            b) Exercise Price.  The exercise price per share of the Common Stock
      under this Warrant shall be $4.00,  subject to adjustment  hereunder  (the
      "Exercise Price").

            c) Cashless Exercise. If at any time after one year from the date of
      issuance of this  Warrant  there is no  effective  Registration  Statement
      registering,  or no current  prospectus  available  for, the resale of the
      Warrant  Shares by the Holder,  then this Warrant may also be exercised at
      such time by means of a "cashless  exercise"  in which the Holder shall be
      entitled to receive a certificate  for the number of Warrant  Shares equal
      to the quotient obtained by dividing [(A-B) (X)] by (A), where:

            (A) = the VWAP on the Trading Day  immediately  preceding the date
                  of such election;

            (B) = the Exercise Price of this Warrant, as adjusted; and

            (X) = the number of Warrant Shares  issuable upon exercise of this
                  Warrant in accordance  with the terms of this Warrant by means
                  of a cash exercise rather than a cashless exercise.

            Notwithstanding  anything herein to the contrary, on the Termination
      Date, this Warrant shall be automatically  exercised via cashless exercise
      pursuant to this Section 2(c).

                                       2
<PAGE>

            d) Exercise Limitations.

                  i.  Holder's  Restrictions.  The Company  shall not effect any
            exercise of this  Warrant,  and a Holder shall not have the right to
            exercise  any portion of this  Warrant,  pursuant to Section 2(c) or
            otherwise,  to the extent that after giving  effect to such issuance
            after  exercise as set forth on the  applicable  Notice of Exercise,
            such Holder (together with such Holder's  Affiliates,  and any other
            person or entity acting as a group  together with such Holder or any
            of such Holder's Affiliates),  as set forth on the applicable Notice
            of  Exercise,  would  beneficially  own in excess of the  Beneficial
            Ownership  Limitation  (as  defined  below).  For  purposes  of  the
            foregoing   sentence,   the   number  of  shares  of  Common   Stock
            beneficially  owned by such Holder and its Affiliates  shall include
            the number of shares of Common Stock  issuable upon exercise of this
            Warrant with respect to which such  determination is being made, but
            shall  exclude  the number of shares of Common  Stock which would be
            issuable upon (A) exercise of the remaining, nonexercised portion of
            this  Warrant  beneficially  owned  by  such  Holder  or  any of its
            Affiliates  and (B) exercise or  conversion  of the  unexercised  or
            nonconverted   portion  of  any  other  securities  of  the  Company
            (including,  without  limitation,  any other Debentures or Warrants)
            subject to a limitation on  conversion or exercise  analogous to the
            limitation contained herein beneficially owned by such Holder or any
            of its  affiliates.  Except as set forth in the preceding  sentence,
            for purposes of this Section 2(d)(i),  beneficial ownership shall be
            calculated in accordance  with Section 13(d) of the Exchange Act and
            the  rules  and  regulations   promulgated   thereunder,   it  being
            acknowledged  by a Holder  that the Company is not  representing  to
            such Holder that such  calculation  is in  compliance  with  Section
            13(d) of the Exchange Act and such Holder is solely  responsible for
            any schedules required to be filed in accordance  therewith.  To the
            extent that the  limitation  contained in this Section 2(d) applies,
            the  determination  of  whether  this  Warrant  is  exercisable  (in
            relation to other  securities owned by such Holder together with any
            Affiliates)  and of which a portion of this  Warrant is  exercisable
            shall be in the sole discretion of a Holder, and the submission of a
            Notice of Exercise shall be deemed to be each Holder's determination
            of  whether  this  Warrant  is  exercisable  (in  relation  to other
            securities owned by such Holder together with any Affiliates) and of
            which portion of this Warrant is  exercisable,  in each case subject
            to such aggregate percentage limitation,  and the Company shall have
            no   obligation   to  verify  or  confirm   the   accuracy  of  such
            determination.  In addition,  a determination as to any group status
            as contemplated above shall be determined in accordance with Section
            13(d) of the Exchange Act and the rules and regulations  promulgated
            thereunder.  For purposes of this Section 2(d), in  determining  the
            number of  outstanding  shares of Common Stock, a Holder may rely on
            the number of outstanding shares of Common Stock as reflected in (x)
            the  Company's  most recent Form 10-Q or Form 10-K,  as the case may
            be, (y) a more recent public  announcement by the Company or (z) any
            other notice by the Company or the Company's  Transfer Agent setting
            forth the

                                       3
<PAGE>

            number of shares of Common  Stock  outstanding.  Upon the written or
            oral request of a Holder,  the Company shall within two Trading Days
            confirm orally and in writing to such Holder the number of shares of
            Common  Stock  then   outstanding.   In  any  case,  the  number  of
            outstanding  shares of Common Stock shall be determined after giving
            effect to the  conversion  or exercise of securities of the Company,
            including this Warrant,  by such Holder or its Affiliates  since the
            date as of which such number of  outstanding  shares of Common Stock
            was reported.  The "Beneficial  Ownership Limitation" shall be 4.99%
            of the number of shares of the Common Stock outstanding  immediately
            after  giving  effect to the  issuance  of  shares  of Common  Stock
            issuable  upon exercise of this Warrant.  The  Beneficial  Ownership
            Limitation  provisions of this Section 2(d)(i) may be waived by such
            Holder, at the election of such Holder,  upon not less than 61 days'
            prior  notice to the  Company  to change  the  Beneficial  Ownership
            Limitation  to 9.99% of the  number of shares  of the  Common  Stock
            outstanding  immediately  after  giving  effect to the  issuance  of
            shares  of Common  Stock  upon  exercise  of this  Warrant,  and the
            provisions of this Section 2(d) shall continue to apply. Upon such a
            change by a Holder of the Beneficial  Ownership Limitation from such
            4.99% limitation to such 9.99% limitation,  the Beneficial Ownership
            Limitation may not be further waived by such Holder.  The provisions
            of this  paragraph  shall be construed and  implemented  in a manner
            otherwise than in strict  conformity  with the terms of this Section
            2(d)(i) to correct this paragraph (or any portion  hereof) which may
            be defective or inconsistent with the intended Beneficial  Ownership
            Limitation  herein  contained  or to  make  changes  or  supplements
            necessary or desirable to properly  give effect to such  limitation.
            The  limitations  contained  in  this  paragraph  shall  apply  to a
            successor holder of this Warrant.

                  ii.  Trading  Market  Restrictions.  If the  Company  has  not
            obtained  Shareholder  Approval (as defined below), then the Company
            may not issue upon  exercise  of this  Warrant a number of shares of
            Common Stock, which, when aggregated with any shares of Common Stock
            issued  (A) upon  conversion  of or as payment  of  interest  on the
            Debentures issued pursuant to the Purchase Agreement, (B) upon prior
            exercise  of  this  or any  other  Warrant  issued  pursuant  to the
            Purchase  Agreement  and (C) pursuant to any warrants  issued to any
            registered  broker-dealer as a fee in connection with the Securities
            pursuant to the  Purchase  Agreement,  would  exceed  19.999% of the
            number of shares of Common  Stock  outstanding  on the  Trading  Day
            immediately  preceding the Closing Date (such number of shares,  the
            "Issuable  Maximum").  If on any attempted exercise of this Warrant,
            the issuance of Warrant Shares would exceed the Issuable Maximum and
            the  Company  shall  not  have  previously   obtained  the  vote  of
            shareholders, if any, as may be required by the applicable rules and
            regulations  of the Nasdaq Capital Market to approve the issuance of
            shares of Common Stock in excess of the Issuable Maximum pursuant to
            the terms  hereof  (the  "Shareholder  Approval"),  then the Company
            shall issue

                                       4
<PAGE>

            to the Holder  requesting a Warrant  exercise such number of Warrant
            Shares as may be issued below the Issuable Maximum and, with respect
            to the remainder of the  aggregate  number of Warrant  Shares,  this
            Warrant  shall  not be  exercisable  until  and  unless  Shareholder
            Approval has been obtained.

      e)    Mechanics of Exercise.

                  i. Authorization of Warrant Shares. The Company covenants that
            all  Warrant  Shares  which may be issued  upon the  exercise of the
            purchase  rights  represented by this Warrant will, upon exercise of
            the purchase rights represented by this Warrant, be duly authorized,
            validly  issued,  fully  paid and  nonassessable  and free  from all
            taxes,  liens and  charges  created by the Company in respect of the
            issue thereof (other than taxes in respect of any transfer occurring
            contemporaneously with such issue).

                  ii. Delivery of Certificates  Upon Exercise.  Certificates for
            shares  purchased  hereunder  shall be  transmitted  by the transfer
            agent of the Company to the Holder by  crediting  the account of the
            Holder's prime broker with the Depository  Trust Company through its
            Deposit  Withdrawal Agent Commission  ("DWAC") system if the Company
            is a participant in such system,  and otherwise by physical delivery
            to the  address  specified  by the Holder in the Notice of  Exercise
            within 3 Trading Days from the delivery to the Company of the Notice
            of  Exercise  Form,  surrender  of this  Warrant (if  required)  and
            payment of the aggregate Exercise Price as set forth above ("Warrant
            Share  Delivery  Date").  This Warrant  shall be deemed to have been
            exercised on the date the Exercise Price is received by the Company.
            The Warrant  Shares shall be deemed to have been issued,  and Holder
            or any  other  person so  designated  to be named  therein  shall be
            deemed to have  become a holder of  record  of such  shares  for all
            purposes,  as of the date the Warrant has been  exercised by payment
            to the Company of the Exercise  Price (or by cashless  exercise,  if
            permitted) and all taxes required to be paid by the Holder,  if any,
            pursuant to Section  2(e)(vii) prior to the issuance of such shares,
            have been paid.

                  iii.  Delivery of New Warrants Upon Exercise.  If this Warrant
            shall have been exercised in part, the Company shall, at the request
            of a Holder and upon surrender of this Warrant  certificate,  at the
            time of delivery of the  certificate  or  certificates  representing
            Warrant  Shares,  deliver  to Holder a new  Warrant  evidencing  the
            rights of Holder to purchase the  unpurchased  Warrant Shares called
            for by this Warrant,  which new Warrant shall in all other  respects
            be identical with this Warrant.

                  iv.  Rescission  Rights.  If the  Company  fails to cause  its
            transfer   agent  to  transmit  to  the  Holder  a  certificate   or
            certificates  representing  the

                                       5
<PAGE>

            Warrant  Shares  pursuant  to this  Section  2(e)(iv) by the Warrant
            Share Delivery Date,  then the Holder will have the right to rescind
            such exercise.

                  v.  Compensation  for  Buy-In on  Failure  to  Timely  Deliver
            Certificates  Upon  Exercise.   In  addition  to  any  other  rights
            available to the Holder,  if the Company fails to cause its transfer
            agent to  transmit  to the  Holder  a  certificate  or  certificates
            representing the Warrant Shares pursuant to an exercise on or before
            the second  Trading Day following the Warrant Share  Delivery  Date,
            and if after  such date the  Holder  is  required  by its  broker to
            purchase  (in an open market  transaction  or  otherwise)  shares of
            Common Stock to deliver in  satisfaction  of a sale by the Holder of
            the Warrant Shares which the Holder anticipated  receiving upon such
            exercise (a "Buy-In"), then the Company shall (1) pay in cash to the
            Holder the amount by which (x) the  Holder's  total  purchase  price
            (including brokerage  commissions,  if any) for the shares of Common
            Stock so purchased  exceeds (y) the amount  obtained by  multiplying
            (A) the number of Warrant  Shares that the  Company was  required to
            deliver to the Holder in connection with the exercise at issue times
            (B) the price at which the sell order  giving rise to such  purchase
            obligation was executed, and (2) at the option of the Holder, either
            reinstate  the  portion  of the  Warrant  and  equivalent  number of
            Warrant Shares for which such exercise was not honored or deliver to
            the Holder the number of shares of Common Stock that would have been
            issued  had the  Company  timely  complied  with  its  exercise  and
            delivery obligations hereunder. For example, if the Holder purchases
            Common  Stock  having a total  purchase  price of $11,000 to cover a
            Buy-In  with  respect to an  attempted  exercise of shares of Common
            Stock with an  aggregate  sale price  giving  rise to such  purchase
            obligation of $10,000, under clause (1) of the immediately preceding
            sentence the Company shall be required to pay the Holder $1,000. The
            Holder  shall  provide the Company  written  notice  indicating  the
            amounts  payable to the Holder in  respect of the Buy-In  and,  upon
            request of the Company, evidence of the amount of such loss. Nothing
            herein  shall  limit a Holder's  right to pursue any other  remedies
            available to it hereunder,  at law or in equity  including,  without
            limitation,  a decree  of  specific  performance  and/or  injunctive
            relief  with  respect to the  Company's  failure  to timely  deliver
            certificates  representing  shares of Common Stock upon  exercise of
            the Warrant as required pursuant to the terms hereof.

                  vi. No Fractional  Shares or Scrip.  No  fractional  shares or
            scrip  representing  fractional  shares  shall  be  issued  upon the
            exercise of this Warrant. As to any fraction of a share which Holder
            would  otherwise  be entitled to purchase  upon such  exercise,  the
            Company  shall at its  election,  either  pay a cash  adjustment  in
            respect of such final  fraction in an amount equal to such  fraction
            multiplied  by the  Exercise  Price or  round  up to the next  whole
            share.

                                       6
<PAGE>

                  vii. Charges, Taxes and Expenses. Issuance of certificates for
            Warrant  Shares shall be made  without  charge to the Holder for any
            issue or transfer tax or other incidental  expense in respect of the
            issuance of such certificate,  all of which taxes and expenses shall
            be paid by the Company, and such certificates shall be issued in the
            name of the  Holder or in such name or names as may be  directed  by
            the Holder;  provided,  however,  that in the event certificates for
            Warrant Shares are to be issued in a name other than the name of the
            Holder,   this  Warrant  when  surrendered  for  exercise  shall  be
            accompanied by the Assignment  Form attached hereto duly executed by
            the Holder; and the Company may require, as a condition thereto, the
            payment of a sum  sufficient  to  reimburse  it for any transfer tax
            incidental thereto.

                  viii.  Closing  of  Books.  The  Company  will not  close  its
            stockholder books or records in any manner which prevents the timely
            exercise of this Warrant, pursuant to the terms hereof.

      Section 3. Certain Adjustments.

            a) Stock  Dividends  and Splits.  If the Company,  at any time while
      this Warrant is outstanding: (A) pays a stock dividend or otherwise make a
      distribution or  distributions  on shares of its Common Stock or any other
      equity or equity equivalent  securities  payable in shares of Common Stock
      (which,  for  avoidance  of doubt,  shall not include any shares of Common
      Stock issued by the Company upon exercise of this Warrant), (B) subdivides
      outstanding  shares of Common  Stock into a larger  number of shares,  (C)
      combines  (including by way of reverse stock split)  outstanding shares of
      Common  Stock  into  a  smaller  number  of  shares,   or  (D)  issues  by
      reclassification of shares of the Common Stock any shares of capital stock
      of the Company,  then in each case the Exercise  Price shall be multiplied
      by a  fraction  of which the  numerator  shall be the  number of shares of
      Common Stock (excluding  treasury shares, if any) outstanding  immediately
      before  such  event and of which the  denominator  shall be the  number of
      shares of Common Stock  outstanding  immediately  after such event and the
      number  of  shares  issuable  upon  exercise  of  this  Warrant  shall  be
      proportionately  adjusted.  Any  adjustment  made pursuant to this Section
      3(a) shall  become  effective  immediately  after the record  date for the
      determination  of  stockholders  entitled  to  receive  such  dividend  or
      distribution  and shall become effective  immediately  after the effective
      date in the case of a subdivision, combination or re-classification.

            b)  Subsequent  Equity  Sales.  If the  Company  or  any  Subsidiary
      thereof,  as  applicable,  at any time while this Warrant is  outstanding,
      shall sell or grant any option to  purchase  or sell or grant any right to
      reprice its securities,  or otherwise dispose of or issue (or announce any
      offer,  sale,  grant or any option to purchase or other  disposition)  any
      Common Stock or Common Stock  Equivalents  entitling any Person to acquire
      shares of Common Stock, at an effective price per share less than the then
      Exercise  Price  (such  lower  price,  the  "Base  Share  Price"  and such
      issuances  collectively,  a  "Dilutive  Issuance")  (if the  holder of the
      Common  Stock or Common  Stock  Equivalents  so issued  shall at any time,
      whether by operation of purchase price adjustments, reset provisions,

                                       7
<PAGE>

      floating conversion,  exercise or exchange prices or otherwise,  or due to
      warrants,  options or rights per share which are issued in connection with
      such  issuance,  be  entitled  to  receive  shares of  Common  Stock at an
      effective  price per share  which is less than the  Exercise  Price,  such
      issuance shall be deemed to have occurred for less than the Exercise Price
      on such date of the Dilutive Issuance),  then, the Exercise Price shall be
      reduced by multiplying the Exercise Price by a fraction,  the numerator of
      which is the  number  of shares of Common  Stock  issued  and  outstanding
      immediately  prior to the Dilutive  Issuance  plus the number of shares of
      Common Stock which the offering  price for such  Dilutive  Issuance  would
      purchase at the then Exercise Price, and the denominator of which shall be
      the sum of the number of shares of Common  Stock  issued  and  outstanding
      immediately  prior to the Dilutive  Issuance  plus the number of shares of
      Common  Stock so  issued  or  issuable  in  connection  with the  Dilutive
      Issuance on a fully converted or exercised basis and the number of Warrant
      Shares  issuable  hereunder  shall be  increased  such that the  aggregate
      Exercise Price payable  hereunder,  after taking into account the decrease
      in the Exercise  Price,  shall be equal to the  aggregate  Exercise  Price
      prior to such  adjustment.  Such  adjustment  shall be made  whenever such
      Common Stock or Common Stock Equivalents are issued.  Notwithstanding  the
      foregoing, no adjustments shall be made, paid or issued under this Section
      3(b) in respect of an Exempt Issuance. The Company shall notify the Holder
      in writing,  no later than the Trading Day  following  the issuance of any
      Common  Stock  or  Common  Stock  Equivalents  subject  to  this  section,
      indicating  therein the applicable  issuance  price,  or applicable  reset
      price,  exchange  price,  conversion  price and other  pricing terms (such
      notice the "Dilutive  Issuance  Notice").  For purposes of  clarification,
      whether or not the Company provides a Dilutive Issuance Notice pursuant to
      this Section 3(b), upon the occurrence of any Dilutive Issuance, after the
      date of such Dilutive  Issuance the Holder is entitled to receive a number
      of Warrant  Shares based upon the Base Share Price  regardless  of whether
      the  Holder  accurately  refers to the Base  Share  Price in the Notice of
      Exercise.

            c) Subsequent  Rights Offerings.  If the Company,  at any time while
      the Warrant is outstanding, shall issue rights, options or warrants to all
      holders of Common Stock (and not to Holders)  entitling  them to subscribe
      for or purchase  shares of Common Stock at a price per share less than the
      VWAP at the record date mentioned below,  then the Exercise Price shall be
      multiplied by a fraction,  of which the denominator shall be the number of
      shares of the Common  Stock  outstanding  on the date of  issuance of such
      rights or warrants  plus the number of  additional  shares of Common Stock
      offered for subscription or purchase,  and of which the numerator shall be
      the  number of  shares  of the  Common  Stock  outstanding  on the date of
      issuance of such rights or  warrants  plus the number of shares  which the
      aggregate  offering  price  of the  total  number  of  shares  so  offered
      (assuming receipt by the Company in full of all consideration payable upon
      exercise of such rights, options or warrants) would purchase at such VWAP.
      Such adjustment shall be made whenever such rights or warrants are issued,
      and shall  become  effective  immediately  after the  record  date for the
      determination of stockholders entitled to receive such rights,  options or
      warrants.

            d) Pro Rata Distributions.  If the Company, at any time prior to the
      Termination Date, shall distribute to all holders of Common Stock (and not
      to  Holders  of the  Warrants)  evidences  of its  indebtedness  or assets
      (including cash and cash dividends)

                                       8
<PAGE>

      or rights or warrants to subscribe for or purchase any security other than
      the Common Stock (which  shall be subject to Section  3(b)),  then in each
      such case the Exercise Price shall be adjusted by multiplying the Exercise
      Price  in  effect   immediately   prior  to  the  record  date  fixed  for
      determination of stockholders  entitled to receive such  distribution by a
      fraction of which the  denominator  shall be the VWAP determined as of the
      record date mentioned above, and of which the numerator shall be such VWAP
      on such  record  date less the then per share  fair  market  value at such
      record date of the portion of such assets or evidence of  indebtedness  so
      distributed  applicable  to one  outstanding  share of the Common Stock as
      determined  by the Board of  Directors  in good faith.  In either case the
      adjustments  shall be described  in a statement  provided to the Holder of
      the portion of assets or evidences of  indebtedness so distributed or such
      subscription  rights  applicable  to  one  share  of  Common  Stock.  Such
      adjustment shall be made whenever any such  distribution is made and shall
      become effective immediately after the record date mentioned above.

            e)  Fundamental  Transaction.  If, at any time while this Warrant is
      outstanding,  (A) the Company effects any merger or  consolidation  of the
      Company with or into another  Person,  (B) the Company effects any sale of
      all or  substantially  all of its  assets  in one or a series  of  related
      transactions,  (C) any tender  offer or  exchange  offer  (whether  by the
      Company  or another  Person) is  completed  pursuant  to which  holders of
      Common Stock are  permitted  to tender or exchange  their shares for other
      securities,   cash  or   property,   or  (D)  the   Company   effects  any
      reclassification  of the Common  Stock or any  compulsory  share  exchange
      pursuant  to which  the  Common  Stock is  effectively  converted  into or
      exchanged  for other  securities,  cash or property  (in any such case,  a
      "Fundamental  Transaction"),  then,  upon any subsequent  exercise of this
      Warrant,  the Holder  shall have the right to  receive,  for each  Warrant
      Share that would have been issuable upon such exercise  immediately  prior
      to the occurrence of such  Fundamental  Transaction,  at the option of the
      Holder, (a) upon exercise of this Warrant,  the number of shares of Common
      Stock of the successor or acquiring  corporation or of the Company,  if it
      is the  surviving  corporation,  and  any  additional  consideration  (the
      "Alternate  Consideration")  receivable  upon  or  as  a  result  of  such
      reorganization,  reclassification, merger, consolidation or disposition of
      assets by a Holder of the number of shares of Common  Stock for which this
      Warrant  is  exercisable  immediately  prior  to such  event or (b) if the
      Company is acquired in an all cash transaction, cash equal to the value of
      this Warrant as  determined in accordance  with the  Black-Scholes  option
      pricing formula.  For purposes of any such exercise,  the determination of
      the  Exercise  Price  shall  be  appropriately  adjusted  to apply to such
      Alternate  Consideration  based on the amount of  Alternate  Consideration
      issuable  in  respect  of one  share of Common  Stock in such  Fundamental
      Transaction,  and the Company shall apportion the Exercise Price among the
      Alternate  Consideration  in a reasonable  manner  reflecting the relative
      value of any  different  components  of the  Alternate  Consideration.  If
      holders of Common Stock are given any choice as to the securities, cash or
      property  to be  received in a  Fundamental  Transaction,  then the Holder
      shall be given  the  same  choice  as to the  Alternate  Consideration  it
      receives  upon any exercise of this  Warrant  following  such  Fundamental
      Transaction.   To  the  extent   necessary  to  effectuate  the  foregoing
      provisions,  any  successor  to the  Company or  surviving  entity in such
      Fundamental Transaction shall issue to the Holder a new warrant consistent
      with  the  foregoing  provisions  and

                                       9
<PAGE>

      evidencing  the Holder's  right to exercise  such  warrant into  Alternate
      Consideration.  The terms of any agreement pursuant to which a Fundamental
      Transaction is effected  shall include terms  requiring any such successor
      or surviving entity to comply with the provisions of this Section 3(e) and
      insuring  that this  Warrant (or any such  replacement  security)  will be
      similarly  adjusted  upon  any  subsequent   transaction  analogous  to  a
      Fundamental Transaction.

            f) Calculations. All calculations under this Section 3 shall be made
      to the nearest cent or the nearest 1/100th of a share, as the case may be.
      For  purposes  of this  Section  3, the  number of shares of Common  Stock
      deemed to be issued and outstanding as of a given date shall be the sum of
      the number of shares of Common Stock (excluding  treasury shares,  if any)
      issued and outstanding.

            g)  Voluntary  Adjustment  By  Company.  The Company may at any time
      during the term of this Warrant reduce the then current  Exercise Price to
      any amount and for any period of time deemed  appropriate  by the Board of
      Directors of the Company.

            h) Notice to Holders.

                        i. Adjustment to Exercise  Price.  Whenever the Exercise
                  Price is adjusted pursuant to any provision of this Section 3,
                  the  Company  shall  promptly  mail to each  Holder  a  notice
                  setting  forth the Exercise  Price after such  adjustment  and
                  setting forth a brief  statement of the facts  requiring  such
                  adjustment.  If the Company  issues a variable rate  security,
                  despite the prohibition thereon in the Purchase Agreement, the
                  Company  shall be deemed to have issued Common Stock or Common
                  Stock  Equivalents  at  the  lowest  possible   conversion  or
                  exercise  price at which such  securities  may be converted or
                  exercised  in the  case of a  Variable  Rate  Transaction  (as
                  defined in the Purchase Agreement).

                        ii.  Notice  to Allow  Exercise  by  Holder.  If (A) the
                  Company shall declare a dividend (or any other distribution in
                  whatever  form) on the Common  Stock;  (B) the  Company  shall
                  declare  a  special   nonrecurring   cash  dividend  on  or  a
                  redemption  of  the  Common  Stock;   (C)  the  Company  shall
                  authorize  the  granting  to all  holders of the Common  Stock
                  rights or warrants to subscribe  for or purchase any shares of
                  capital stock of any class or of any rights;  (D) the approval
                  of any  stockholders  of the  Company  shall  be  required  in
                  connection with any  reclassification of the Common Stock, any
                  consolidation  or merger to which the Company is a party,  any
                  sale or transfer of all or substantially  all of the assets of
                  the Company,  of any  compulsory  share  exchange  whereby the
                  Common  Stock is  converted  into  other  securities,  cash or
                  property;  (E) the Company  shall  authorize  the voluntary or
                  involuntary  dissolution,  liquidation  or  winding  up of the
                  affairs of the Company;  then, in each case, the Company shall
                  cause to be mailed to the  Holder  at its last  address  as it
                  shall  appear upon the Warrant  Register  of the  Company,  at
                  least 20  calendar  days  prior to the  applicable  record  or
                  effective date hereinafter specified, a notice stating

                                       10
<PAGE>

                  (x) the date on which a record is to be taken for the  purpose
                  of  such  dividend,   distribution,   redemption,   rights  or
                  warrants,  or if a record is not to be  taken,  the date as of
                  which the holders of the Common Stock of record to be entitled
                  to  such  dividend,   distributions,   redemption,  rights  or
                  warrants  are to be  determined  or (y) the date on which such
                  reclassification,  consolidation,  merger,  sale,  transfer or
                  share exchange is expected to become  effective or close,  and
                  the date as of which it is expected that holders of the Common
                  Stock of record shall be entitled to exchange  their shares of
                  the  Common  Stock  for  securities,  cash or  other  property
                  deliverable upon such reclassification, consolidation, merger,
                  sale, transfer or share exchange; provided that the failure to
                  mail  such  notice or any  defect  therein  or in the  mailing
                  thereof shall not affect the validity of the corporate  action
                  required  to be  specified  in  such  notice.  The  Holder  is
                  entitled to exercise  this  Warrant  during the 20-day  period
                  commencing on the date of such notice to the effective date of
                  the event triggering such notice.

      Section 4. Transfer of Warrant.

            a)  Transferability.  Subject  to  compliance  with  any  applicable
      securities laws and the conditions set forth in Section 4(d) hereof and to
      the provisions of Section 4.1 of the Purchase Agreement,  this Warrant and
      all rights  hereunder  (including,  without  limitation,  any registration
      rights) are  transferable,  in whole or in part,  upon  surrender  of this
      Warrant at the principal  office of the Company or its  designated  agent,
      together with a written  assignment of this Warrant  substantially  in the
      form attached  hereto duly executed by the Holder or its agent or attorney
      and funds  sufficient to pay any transfer taxes payable upon the making of
      such transfer.  Upon such surrender  and, if required,  such payment,  the
      Company shall execute and deliver a new Warrant or Warrants in the name of
      the  assignee  or  assignees  and in  the  denomination  or  denominations
      specified  in such  instrument  of  assignment,  and  shall  issue  to the
      assignor a new  Warrant  evidencing  the  portion of this  Warrant  not so
      assigned,  and this Warrant  shall  promptly be cancelled.  A Warrant,  if
      properly  assigned,  may be  exercised by a new holder for the purchase of
      Warrant Shares without having a new Warrant issued.

            b) New Warrants.  This Warrant may be divided or combined with other
      Warrants upon presentation  hereof at the aforesaid office of the Company,
      together with a written notice  specifying the names and  denominations in
      which new Warrants are to be issued,  signed by the Holder or its agent or
      attorney.  Subject to  compliance  with Section  4(a),  as to any transfer
      which may be involved in such division or  combination,  the Company shall
      execute and deliver a new Warrant or Warrants in exchange  for the Warrant
      or Warrants to be divided or combined in accordance with such notice.

            c) Warrant Register.  The Company shall register this Warrant,  upon
      records to be  maintained  by the Company for that purpose  (the  "Warrant
      Register"), in the name of the record Holder hereof from time to time. The
      Company may deem and treat the  registered  Holder of this  Warrant as the
      absolute owner hereof for the purpose of any

                                       11
<PAGE>

      exercise  hereof  or any  distribution  to the  Holder,  and for all other
      purposes, absent actual notice to the contrary.

            d) Transfer  Restrictions.  If, at the time of the surrender of this
      Warrant in connection  with any transfer of this Warrant,  the transfer of
      this Warrant shall not be registered pursuant to an effective registration
      statement under the Securities Act and under  applicable  state securities
      or blue sky laws, the Company may require, as a condition of allowing such
      transfer (i) that the Holder or transferee  of this  Warrant,  as the case
      may be, furnish to the Company a written opinion of counsel (which opinion
      shall be in form, substance and scope customary for opinions of counsel in
      comparable  transactions)  to the effect  that such  transfer  may be made
      without  registration  under the Securities Act and under applicable state
      securities or blue sky laws,  (ii) that the holder or  transferee  execute
      and  deliver to the  Company an  investment  letter in form and  substance
      acceptable to the Company and (iii) that the  transferee be an "accredited
      investor" as defined in Rule 501(a)(1),  (a)(2), (a)(3), (a)(7), or (a)(8)
      promulgated under the Securities Act or a "qualified  institutional buyer"
      as defined in Rule 144A(a) under the Securities Act.

      Section 5. Miscellaneous.

            a) No Rights as Shareholder  Until  Exercise.  This Warrant does not
      entitle the Holder to any voting  rights or other rights as a  shareholder
      of the  Company  prior to the  exercise  hereof  as set  forth in  Section
      2(e)(ii).

            b) Loss,  Theft,  Destruction or Mutilation of Warrant.  The Company
      covenants  that  upon  receipt  by  the  Company  of  evidence  reasonably
      satisfactory to it of the loss,  theft,  destruction or mutilation of this
      Warrant or any stock  certificate  relating to the Warrant Shares,  and in
      case of loss,  theft or destruction,  of indemnity or security  reasonably
      satisfactory to it (which,  in the case of the Warrant,  shall not include
      the posting of any bond),  and upon  surrender  and  cancellation  of such
      Warrant or stock  certificate,  if  mutilated,  the Company  will make and
      deliver a new Warrant or stock  certificate  of like tenor and dated as of
      such cancellation, in lieu of such Warrant or stock certificate.

            c) Saturdays,  Sundays,  Holidays, etc. If the last or appointed day
      for the taking of any action or the  expiration  of any right  required or
      granted  herein shall not be a Business Day, then such action may be taken
      or such right may be exercised on the next succeeding Business Day.

            d) Authorized Shares.

                  The  Company  covenants  that during the period the Warrant is
            outstanding, it will reserve from its authorized and unissued Common
            Stock a  sufficient  number of shares to provide for the issuance of
            the Warrant  Shares upon the exercise of any  purchase  rights under
            this Warrant.  The Company  further  covenants  that its issuance of
            this Warrant shall constitute full authority to its officers who are
            charged with the duty of executing stock certificates to execute

                                       12
<PAGE>

            and issue the necessary certificates for the Warrant Shares upon the
            exercise of the purchase rights under this Warrant. The Company will
            take all such  reasonable  action as may be necessary to assure that
            such  Warrant  Shares  may be  issued  as  provided  herein  without
            violation  of  any  applicable   law  or   regulation,   or  of  any
            requirements  of the Trading  Market upon which the Common Stock may
            be listed.

                  Except  and to the  extent as waived  or  consented  to by the
            Holder,  the  Company  shall not by any action,  including,  without
            limitation, amending its certificate of incorporation or through any
            reorganization,   transfer   of   assets,   consolidation,   merger,
            dissolution,  issue or sale of  securities  or any  other  voluntary
            action,  avoid or seek to avoid the observance or performance of any
            of the terms of this  Warrant,  but will at all times in good  faith
            assist in the  carrying  out of all such  terms and in the taking of
            all such actions as may be necessary or  appropriate  to protect the
            rights of Holder as set forth in this  Warrant  against  impairment.
            Without  limiting the generality of the foregoing,  the Company will
            (a) not  increase  the par  value of any  Warrant  Shares  above the
            amount payable therefor upon such exercise immediately prior to such
            increase in par value,  (b) take all such action as may be necessary
            or  appropriate  in order that the  Company  may validly and legally
            issue fully paid and nonassessable  Warrant Shares upon the exercise
            of this  Warrant,  and (c) use  commercially  reasonable  efforts to
            obtain all such  authorizations,  exemptions  or  consents  from any
            public  regulatory  body  having  jurisdiction  thereof  as  may  be
            necessary  to enable the  Company to perform its  obligations  under
            this Warrant.

                  Before  taking any action which would result in an  adjustment
            in  the  number  of  Warrant   Shares  for  which  this  Warrant  is
            exercisable or in the Exercise  Price,  the Company shall obtain all
            such  authorizations or exemptions  thereof, or consents thereto, as
            may be necessary  from any public  regulatory  body or bodies having
            jurisdiction thereof.

            e)  Jurisdiction.   All  questions   concerning  the   construction,
      validity,   enforcement  and  interpretation  of  this  Warrant  shall  be
      determined in accordance with the provisions of the Purchase Agreement.

            f)  Restrictions.  The Holder  acknowledges  that the Warrant Shares
      acquired upon the exercise of this Warrant,  if not registered,  will have
      restrictions upon resale imposed by state and federal securities laws.

            g)  Nonwaiver  and  Expenses.  No course of  dealing or any delay or
      failure  to  exercise  any right  hereunder  on the part of  Holder  shall
      operate as a waiver of such right or otherwise  prejudice Holder's rights,
      powers or  remedies,  notwithstanding  the fact that all rights  hereunder
      terminate on the Termination  Date. If the Company willfully and knowingly
      fails to comply with any provision of this  Warrant,  which results in any
      material  damages to the  Holder,  the  Company  shall pay to Holder  such
      amounts as shall be sufficient to cover any costs and expenses  including,
      but not  limited  to,  reasonable  attorneys'  fees,  including  those  of
      appellate  proceedings,  incurred by Holder in collecting

                                       13
<PAGE>

      any amounts  due  pursuant  hereto or in  otherwise  enforcing  any of its
      rights, powers or remedies hereunder.

            h)  Notices.  Any  notice,  request or other  document  required  or
      permitted to be given or  delivered to the Holder by the Company  shall be
      delivered  in  accordance  with  the  notice  provisions  of the  Purchase
      Agreement.

            i) Limitation of Liability.  No provision  hereof, in the absence of
      any  affirmative  action by Holder to  exercise  this  Warrant to purchase
      Warrant Shares,  and no enumeration  herein of the rights or privileges of
      Holder,  shall give rise to any liability of Holder for the purchase price
      of any Common  Stock or as a  stockholder  of the  Company,  whether  such
      liability is asserted by the Company or by creditors of the Company.

            j) Remedies.  Holder,  in addition to being entitled to exercise all
      rights granted by law, including recovery of damages,  will be entitled to
      specific  performance of its rights under this Warrant. The Company agrees
      that  monetary  damages  would not be adequate  compensation  for any loss
      incurred by reason of a breach by it of the provisions of this Warrant and
      hereby  agrees to waive and not to assert  the  defense  in any action for
      specific performance that a remedy at law would be adequate.

            k) Successors and Assigns.  Subject to applicable  securities  laws,
      this Warrant and the rights and obligations  evidenced  hereby shall inure
      to the benefit of and be binding  upon the  successors  of the Company and
      the  successors  and permitted  assigns of Holder.  The provisions of this
      Warrant are  intended  to be for the  benefit of all Holders  from time to
      time of this Warrant and shall be enforceable by any such Holder or holder
      of Warrant Shares.

            l)  Amendment.  This  Warrant  may be  modified  or  amended  or the
      provisions  hereof waived with the written  consent of the Company and the
      Holder.

            m) Severability.  Wherever possible,  each provision of this Warrant
      shall be  interpreted  in such manner as to be  effective  and valid under
      applicable  law, but if any  provision of this Warrant shall be prohibited
      by or invalid under applicable law, such provision shall be ineffective to
      the extent of such  prohibition or invalidity,  without  invalidating  the
      remainder of such provisions or the remaining provisions of this Warrant.

            n)  Headings.  The  headings  used  in  this  Warrant  are  for  the
      convenience of reference only and shall not, for any purpose,  be deemed a
      part of this Warrant.

                              ********************

                                       14
<PAGE>

            IN  WITNESS  WHEREOF,  the  Company  has caused  this  Warrant to be
executed by its officer thereunto duly authorized.

Dated:  August ___, 2006

                                   ABLE ENERGY, INC.

                                   By:__________________________________________
                                      Name:
                                      Title:

                                       15
<PAGE>

                               NOTICE OF EXERCISE

TO: ABLE ENERGY, INC.

            (1) The  undersigned  hereby  elects to  purchase  ________  Warrant
Shares of the Company  pursuant to the terms of the  attached  Warrant  (only if
exercised in full),  and tenders herewith payment of the exercise price in full,
together with all applicable transfer taxes, if any.

            (2) Payment shall take the form of (check applicable box):

                      [ ] in lawful money of the United States; or

                      [ ] [if  permitted]  the  cancellation  of such  number of
                      Warrant  Shares as is necessary,  in  accordance  with the
                      formula set forth in  subsection  2(c),  to exercise  this
                      Warrant  with  respect  to the  maximum  number of Warrant
                      Shares  purchasable  pursuant  to  the  cashless  exercise
                      procedure set forth in subsection 2(c).

            (3) Please issue a certificate  or  certificates  representing  said
Warrant  Shares  in the  name of the  undersigned  or in such  other  name as is
specified below:

               --------------------------------------

The Warrant Shares shall be delivered to the following DWAC Account Number or by
physical delivery of a certificate to:

               --------------------------------------

               --------------------------------------

               --------------------------------------

            (4) Accredited Investor. The undersigned is an "accredited investor"
as defined in  Regulation D  promulgated  under the  Securities  Act of 1933, as
amended.

[SIGNATURE OF HOLDER]

Name of Investing Entity: _____________________________________________________

Signature of Authorized Signatory of Investing Entity: ________________________

Name of Authorized Signatory: _________________________________________________

Title of Authorized Signatory: ________________________________________________

Date: _________________________________________________________________________

<PAGE>
                                 ASSIGNMENT FORM

                    (To assign the foregoing warrant, execute
                   this form and supply required information.
                 Do not use this form to exercise the warrant.)

            FOR  VALUE  RECEIVED,  [____]  all  of or  [_______]  shares  of the
foregoing Warrant and all rights evidenced thereby are hereby assigned to

_______________________________________________ whose address is

______________________________________________________________.

______________________________________________________________

                                              Dated:  ______________, _______

                      Holder's Signature:   _____________________________

                      Holder's Address:     _____________________________

                                            _____________________________

Signature Guaranteed:  ___________________________________________

NOTE: The signature to this  Assignment Form must correspond with the name as it
appears on the face of the Warrant,  without  alteration or  enlargement  or any
change whatsoever,  and must be guaranteed by a bank or trust company.  Officers
of corporations and those acting in a fiduciary or other representative capacity
should file proper evidence of authority to assign the foregoing Warrant.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00108-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00108-of-00352.parquet"}]]